Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 220,856,451 papers from all fields of science
Search
Sign In
Create Free Account
TVX 2656
Known as:
2-propenoic acid, 3-(3,4,5-trimethoxyphenyl)-, 1-((4-methyl-7-((4-morpholinylcarbonyl)amino)-2-oxo-2H-1-benzopyran-3-yl)methyl)-2-(4-morpholinyl)ethyl ester, monohydrochloride
, TVX-2656
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Morpholines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The interoceptive discriminative stimuli induced by the novel putative anxiolytic TVX Q 7821: behavioral evidence for the specific involvement of serotonin 5-HT1A receptors
D. Spencer
,
J. Traber
Psychopharmacology
2004
Corpus ID: 10335914
TVX Q 7821 is active in several behavioral models of anxiety in animals and has a high selective affinity for brain serotonin 5…
Expand
Highly Cited
1987
Highly Cited
1987
Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion.
S. Lorens
,
L. D. van de Kar
Neuroendocrinology
1987
Corpus ID: 46853027
The present study was designed to investigate the effect of distinct serotonin (5-HT1A and 5-HT2) agonists and antagonists on…
Expand
Highly Cited
1984
Highly Cited
1984
Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821
J. Traber
,
M. Davies
,
W. Dompert
,
T. Glaser
,
T. Schuurman
,
P. Seidel
Brain Research Bulletin
1984
Corpus ID: 4699522
1977
1977
New coronary active benzopyranone derivatives
H. Jacobi
,
K. Boltze
,
P. Seidel
,
H. Schwarz
Die Naturwissenschaften
1977
Corpus ID: 30805856
For some time now, 2-benzopyranone derivatives have been used in human medicine for the prophylaxis and therapy of coronary heart…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required